Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Nichi-Iko

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Nichi-Iko's Japan sales performance.

Shionogi’s antiviral COVID-19 treatment meets phase 3 primary endpoint

Shionogi’s antiviral COVID-19 treatment meets phase 3 primary endpoint

A total of 1, 821 predominantly vaccinated patients were enrolled in Japan, South Korea and Vietnam, irrespective of risk factors for COVID-19 progression. ... Japan and the US Food and Drug Administration (FDA), based on their scientific and medical

Biogen and Eisai’s lecanemab shows promise in confirmatory Alzheimer’s study

Biogen and Eisai’s lecanemab shows promise in confirmatory Alzheimer’s study Eisai outlined that it will discuss the data with regulatory authorities in the US, Japan and Europe, and aims to file for traditional approval in the US, as well as marketing ... authorisation applications in Japan and Europe, by 2023.

EC approves Alexion's Ultomiris as generalised myasthenia gravis treatment

EC approves Alexion's Ultomiris as generalised myasthenia gravis treatment In April 2022 Ultomiris was approved in the US and, in the same year, was then approved in Japan for certain adults with gMG.

Novavax’s COVID-19 vaccine candidate receives EC approval for use as a booster

Novavax’s COVID-19 vaccine candidate receives EC approval for use as a booster Nuvaxovid has also been approved in Japan, Australia and New Zealand as a booster in adults aged 18 years and older, and is actively under review in other markets.

AstraZeneca’s Imfinzi plus chemotherapy shows promise for advanced biliary tract cancer

AstraZeneca’s Imfinzi plus chemotherapy shows promise for advanced biliary tract cancer Regulatory applications are also currently under review in Europe, Japan and several other countries based on the TOPAZ-1 results, the company outlined. ... Approximately 50, 000 people in Europe, the US and Japan and around 210, 000 people worldwide are

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...

Latest intelligence

Report: Reinventing product and portfolio value for the biopharmaceutical industry
Gain practical advice on determining and communicating product and portfolio value, including why, in fast-paced and evolving markets, you need to consider the evidence requirements of a growing network of...
Neil Thompson
How AI is finally helping rare diseases gain more than just attention
By Neil Thompson...
Is communication failing us?
Compelling people to care in a world oversaturated with news and information...